Opinion - Page 57

This is the web version of ASH in 30 Seconds, STAT’s report from the American Society of Hematology meeting. And on the last day of ASH, the sun shone once again. Thanks

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Scroll down for the sixth installment of American Science, Shattered, brought to

This is the online version of ASH in 30 Seconds, STAT’s report from the American Society of Hematology meeting. Sign up for the email version here.  It rains in Florida. A lot. This

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Apparently, some vets are already using GLP-1s for diabetic cats. We are all a clinical trial or

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning and happy Monday. There’s a lot to cover today — thanks for

This is the online version of ASH in 30 Seconds, STAT’s report from the American Society of Hematology meeting. Sign up for the email version here.  It’s Day 2 of the ASH

Fulcrum Therapeutics said Sunday that a higher dose of its experimental pill for sickle cell disease was more effective at inducing an alternative form of the oxygen-carrying molecule hemoglobin — boosting hopes

This is the online version of ASH in 30 Seconds, STAT’s report from the American Society of Hematology meeting. Sign up for the email version here.  We hear most of the country

The Advisory Committee on Immunization Practices’ (ACIP) meetings used to be a geek’s dream: hours of long, maybe dreary presentation of extensive data followed by lengthy discussions that drilled into details of

WASHINGTON — Federal vaccine advisers, through a freewheeling, and at times combative two-day meeting, recommended a major change to childhood vaccinations that runs counter to the medical consensus — and began setting